Q4 2025 Rockwell Medical Inc Earnings Call Transcript
Key Points
- Rockwell Medical Inc (RMTI) maintained profitability on an adjusted EBITDA basis for the second consecutive year.
- The company achieved one of the highest quarterly gross margins in its history during the fourth quarter of 2025.
- Rockwell Medical Inc (RMTI) generated positive cash flow from operations in the fourth quarter, resulting in a higher cash position at year-end.
- The company successfully diversified its customer base, reducing customer concentration risk and improving revenue stability.
- Rockwell Medical Inc (RMTI) expanded its relationship with key customers, including Fresenius and DaVita, and signed new agreements with Innovative Renal Care and Concerto Reno Services.
- Net sales for the full year 2025 decreased by 32% compared to 2024, driven by a reduction in purchase volumes from a major customer.
- The company reported a net loss of $5.2 million for the full year 2025, compared to a net loss of $500,000 in 2024.
- Gross profit for the full year 2025 decreased from $17.5 million in 2024 to $11.7 million.
- The decrease in net sales and gross profit was attributed to the expected reduction in purchase volumes by one of Rockwell Medical Inc (RMTI)'s customers.
- Despite improvements, the company still faces challenges in expanding its customer base and securing long-term agreements with major clients like DaVita.
Good morning, and welcome to Rockwell Medical's fourth-quarter and full year 2025 results conference call and webcast. Please note, this event is being recorded. At this time, I would like to turn the conference call over to Heather Hunter, Chief Operating Officer at Rockwell Medical. Heather, please go ahead.
Good morning, and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Rockwell Medical's President and Chief Executive Officer, Dr. Mark Strobeck; and Rockwell Medical's Chief Financial Officer; Jesse Neri.
Before we begin, I would like to remind you that this conference call will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking in our annual report on Form 10-K and our subsequent periodic reports filed with the SEC. These statements are subject to risks and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
